SCHEMBL304574

SCHEMBL304574

CC(C)C(=O)OCI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chloroform SCHEMBL8311625 0.92 NPC1 (0.32)
SCHEMBL17899451 0.80
SCHEMBL79434 0.79
SCHEMBL2865670 0.78
SCHEMBL8788251 0.78
SCHEMBL8788253 0.78
SCHEMBL16559351 0.78 CA12 (0.32)
SCHEMBL681184 0.75 ELANE (0.34)
Ethylene Glycol Diisobutanoate SCHEMBL843146 0.75 TSHR (0.36)
SCHEMBL3076658 0.74 CA2 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115925640-B ((3-Carbamoyl-5-fluoropyrazin-2-yl) oxy) methyl isobutyrate and preparation method and application thereof 中国人民解放军军事科学院军事医学研究院 2025-03-28 CN claimed
CN-115925640-A ((3-carbamoyl-5-fluoropyrazin-2-yl) oxy) methyl isobutyrate and preparation method and application thereof 中国人民解放军军事科学院军事医学研究院 2023-04-07 CN claimed
US-9359376-B2 Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds SPHAERA PHARMA PTE. LTD (SG) 2016-06-07 US claimed
US-20140121367-A1 SUBSTITUTED METHYLFORMYL REAGENTS AND METHOD OF USING SAME TO MODIFY PHYSICOCHEMICAL AND/OR PHARMACOKINETIC PROPERTIES OF COMPOUNDS PIVOT HOLDING LLC 2014-05-01 US claimed
EP-2693876-A1 SUBSTITUTED METHYLFORMYL REAGENTS AND METHOD OF USING SAME TO MODIFY PHYSICOCHEMICAL AND/OR PHARMACOKINETIC PROPERTIES OF COMPOUNDS Sphaera Pharma Pte. Ltd (SG) 2014-02-12 EP claimed
WO-2012137225-A1 SUBSTITUTED METHYLFORMYL REAGENTS AND METHOD OF USING SAME TO MODIFY PHYSICOCHEMICAL AND/OR PHARMACOKINETIC PROPERTIES OF COMPOUNDS SPHAERA PHARMA PVT. LTD (IN) 2012-10-11 WO claimed
CN-122079989-A Diazabicyclo beta-lactamase inhibitor and application thereof 2026-05-26 CN disclosed
US-20260115175-A1 NICORANDIL DERIVATIVES UNICYCIVE THERAPEUTICS INC (US) 2026-04-30 US disclosed
EP-3937938-B1 NICORANDIL DERIVATIVES UNICYCIVE THERAPEUTICS INC (US) 2026-01-28 EP disclosed
US-12396989-B2 Nicorandil derivatives UNICYCIVE THERAPEUTICS, INC. (US) 2025-08-26 US disclosed
US-12377082-B2 Nicorandil derivatives Unicycive Therapeutics Inc. (US) 2025-08-05 US disclosed
US-20250215030-A1 STAT MODULATORS AND USES THEREOF RECLUDIX PHARMA, INC. 2025-07-03 US disclosed
US-20250215029-A1 STAT MODULATORS AND USES THEREOF RECLUDIX PHARMA, INC. 2025-07-03 US disclosed
US-4487927-A BACTERICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-12-11 US disclosed
EP-0123024-A2 7-Acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them; their starting compounds and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-31 EP disclosed
US-4463002-A Syn-isomers of 7-substituted-3-cephem-4-carboxylic acid esters FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-07-31 US disclosed
US-4423213-A ANTIBIOTIC FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-12-27 US disclosed
US-4409214-A Including cefixime; antibiotics FUJISAWA PHARMACEUTICAL, CO., LTD. (JP) 1983-10-11 US disclosed
EP-0065745-A2 Syn-isomers of 7-substituted-3-cephem-4-carboxylic acid esters, and a process for production thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1982-12-01 EP disclosed
EP-0030630-A2 7-Acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them; their starting compounds and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-06-24 EP disclosed